ArticleBMC cancer2012

Reduced CYP2D6 function is associated with gefitinib-induced rash in patients with non-small cell lung cancer.

Tomohiro Suzumura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.